News Feed Opinion Blog Posts Career Updates Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
September, 2025
September 2025
M T W T F S S
1234567
891011121314
15161718192021
22232425262728
2930  
John Fesko Reflects on IMvigor011 Bladder Cancer Trial 
John Fesko/LinkedIn
Aug 19, 2025, 12:28

John Fesko Reflects on IMvigor011 Bladder Cancer Trial 

John Fesko, President and Chief Business Officer at Natera, shared a post on LinkedIn:

“15 years ago, seeing someone I love decline chemo for muscle-invasive bladder cancer sparked my interest in circulating tumor DNA. Today, Genentech’s Phase 3 Atezolizumab results, as Professor Thomas Powles notes, open the door to ‘a new treatment paradigm’ for patients who are ‘positive for recurrence on a molecular level but have no evidence of disease on imaging.'”

John Fesko

Read More about IMvigor011 Trial on OncoDaily.

John Fesko Reflects on IMvigor011 Bladder Cancer Trial 

bladder cancer cancer IMVIGOR011 Bladder Cancer Trial OncoDaily Oncology Thomas Powles
Special Coverage
Voices
Sep 7, 2025, 15:52
Muhammad Umair Mushtaq: From Love to Global Good in Hematology
Science
Sep 7, 2025, 15:52
Paolo Tarantino: ctDNA Analysis of SONIA Has Been Published in Nature Medicine
Insight
Sep 7, 2025, 15:47
Highlights from SOHO 2025 Annual Meeting
Voices
Sep 7, 2025, 15:42
Brunilda Profka Haxhiu: Radiotherapy Must be Seen as a Right, not a Privilege
Voices
Sep 7, 2025, 15:41
Lisa Lacasse: Highlighting the Potential of Multi-Cancer Early Detection Tests
Blog Posts
Sep 7, 2025, 15:37
Ana Barac: New Era of Myocardial Strain at ASE 2025
Voices
Sep 7, 2025, 15:32
Sumanta Pal: Contribution of IO in TKI/IO Combinations For Non-Clear Cell Kidney Cancer
Voices
Sep 7, 2025, 15:24
Katie Coleman: “What Do Patients Want” is a Moving Target
Insight
Sep 7, 2025, 15:17
Udhayvir Grewal: Palliative Care and End-of-Life Care in Esophageal Cancer
Voices
Sep 7, 2025, 14:57
Zeynep Ozay: Learning and Growing at Huntsman Cancer Institute
Insight
Sep 7, 2025, 14:57
Gerry Hanna Spotlights Editorial on Reframing Radiotherapy in Radiation Oncology
Voices
Sep 7, 2025, 14:41
Roberto Borea: My Very First WCLC 2025 as an IASLC Academy Member